THALIDOMIDE AND BORTEZOMIB INDUCED INTERSTITIAL PNEUMONITIS IN PATIENT WITH MUTIPLE MYELOMA
Kamreddy Sushma* and Dr. Pradeep Kumar Challa
Long term use of the combination of the thalidomide and bortezomib is associated with the risk of interstitial pneumonia in individuals with the multiple myeloma. Here is the case of the 48years old male who has the history of the multiple myeloma since 4 ½ years and was on chemotherapy with thalidomide and bortezomib since 4years. Patient has the history of the bronchial asthma since childhood and uses inhaler occasionally. Complaints of shortness of breath(grade-iv), cough since 1year.
Keywords: Interstitial pneumonitis, thalidomide, bortezomib, multiple myeloma.
[Full Text Article]